Business Development

This is the official website of IBSA fully dedicated to Business Development and Licensing activities.

LICENSING

The Business Development Dept. is constantly looking for partners and international distributors for licensing agreements in countries where IBSA does not operate directly with its branches. IBSA is focused on strategic collaborations to achieve a common goal while sharing responsibilities, resources, risks and rewards. Close ties with local distributors are crucial for IBSA to grow at an international level. The Business Development Dept. also evaluates licensing-in opportunities for the expansion of product portfolio.

Discover our products

IBSA’s Orodispersible film products

Find out more about our innovative dosing method for the oral administration of active substances.

Request the brochure

Dermatology diseases

Find out more about our wide range of products for skincare

Request the brochure

Technologies & products for the wellbeing of men and women

Find out more about IBSA's help for the diseases of the male/female urological systems.

Request the brochure

Technologies & products for the wellbeing of women

Find out more about IBSA's help for the diseases of the female urogenital system.

Request the brochure

Innovative technology and effective responses at the service of men and women

Find out more about IBSA's products specifically formulated for the improvement of sperm parameters in infertile men and for the health of mother and child.

Request the brochure

October 8th-10th

Visit us at our stand 14A30
zone Finished Dosage Formulations

Product catalogue and brochures

Sinovial

Dermatology

Technologies & products for the wellbeing of women

Urological wellbeing of men and women

Ibsa’s Orodispersible film products

Male fertility and pregnancy

Export catalogue

IBSA Sustainability Report

Orodispersible film technologies

Soft Gel

Technologies brochure

Corporate brochure

IBSA Company

Shaping the future of human possibilities

We are a multinational pharmaceutical company with a specific vision of care that we project from our headquarters in Switzerland to the rest of the world, through a process of on-going expansion in Europe, Asia and North America.

BLOG

+

05.03.2024

ARTROSIS Y VISCOSUPLEMENTACIÓN – Publirreportaje – Chemistry Today

Artrosis, la causa más frecuente de discapacidad musculoesquelética. Descubramos más con la TECNOLOGÍA HÍBRIDA NAHYCO® de IBSA.

+

05.03.2024

OSTEOARTHRITIS AND VISCOSUPPLEMENTATION – Advertorial – Chemistry today

Osteoarthritis, the most common cause of musculoskeletal disability. Let’s find out more with the IBSA NAHYCO® HYBRID TECHNOLOGY.

+

31.10.2023

Unas palabras con Andrea Taborelli – Entrevista con Chimica Oggi – Chemistry Today

Andrea Toborelli, Director de Desarrollo Empresarial y Licencias de IBSA, fue entrevistado por Nutra Horizons.